oribiotech.com Founded Year 2015 Stage Series B| Alive Total Raised $139.4M Last Raised $100M| 3 yrs ago About Ori Biotech Ori Biotech specializes in the field of cell and gene therapy (CGT) manufacturing and offers a platform designed to manage the production of personalized lifesaving treat...
Ori Biotech hasraised $139.4Mover3 rounds. Ori Biotech'slatest funding roundwas aSeries B for $100MonJanuary 18, 2022. Date Round Amount Investors Valuation Revenue Sources 1/18/2022 Series B $100M Novalis LifeSciences,Amadeus Capital Partners,Chimera Investments,Delin Ventures,Northpond Ventures,...
产品厂商:cil(Cambridge Isotope Laboratories) 产品文档: 简单介绍: 美国剑桥CIL同位素标记&氘代试剂之-Anhydro-(O-carboxyphenyl)phosphorochloridate,货号:MI-6870(Anhydro-(O-carboxyphenyl)phosphorochloridate) 详情介绍: Anhydro-(O-carboxyphenyl)phosphorochloridate ...